Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricky D Turgeon

Showing results (51-60 of 116) with videos related to

Pageof 12
Sort By:
International Journal of Clinical Pharmacy|January 7, 2017
Ceftaroline fosamil for community-acquired pneumonia and skin and skin structure infections: a systematic reviewMaguy Saffouh El Hajj, Ricky D Turgeon, Kyle John Wilby
The Canadian Journal of Hospital Pharmacy|September 13, 2017
Pharmacist Performance of Physical Assessment: Perspectives of Clinical Pharmacists Working in Different Practice SettingsDoson Chua, Fatima Ladha, Robert T Pammett, et al.
The Canadian Journal of Hospital Pharmacy|March 5, 2019
Evaluation of Physical Assessment Education for Practising Pharmacists: A Cross-Sectional SurveyArden R Barry, Greg Egan, Ricky D Turgeon, et al.
The American Journal of Medicine|January 3, 2015
Antiviral treatment of Bell's palsy based on baseline severity: a systematic review and meta-analysisRicky D Turgeon, Kyle J Wilby, Mary H H Ensom
Canadian Family Physician Medecin De Famille Canadien|December 15, 2021
Medication management for heart failure with reduced ejection fraction: Clinical pearls for optimizing evidenced-informed therapyArden R Barry, Lynette Kosar, Sheri L Koshman, et al.
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|January 14, 2016
Updated guidelines for the management of dyslipidemia and prevention of cardiovascular disease by pharmacistsRicky D Turgeon, Todd J Anderson, Jean Grégoire, et al.
European Cardiology|April 18, 2022
Cryoablation or Drug Therapy for Initial Treatment of Atrial FibrillationJason G Andrade, Ricky D Turgeon, Laurent Macle, et al.
ESC Heart Failure|February 19, 2026
Independent external validation of the LIFE-HF clinical prediction model using the GUIDE-IT trialRicky D Turgeon, Nathaniel M Hawkins, Mohsen Sadatsafavi, et al.
European Heart Journal|March 17, 2022
P2Y12 inhibitor adherence trajectories in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prognostic implicationsRicky D Turgeon, Sheri L Koshman, Yuan Dong, et al.
The Canadian Journal of Hospital Pharmacy|January 27, 2017
Characterization of Venous Thromboembolism Risk in Medical Inpatients Using Different Clinical Risk Assessment ModelsReza Rafizadeh, Ricky D Turgeon, Josh Batterink, et al.
Pageof 12

Showing results (51-60 of 116) with videos related to

Sort By:
Pageof 12
International Journal of Clinical Pharmacy|January 7, 2017
Ceftaroline fosamil for community-acquired pneumonia and skin and skin structure infections: a systematic reviewMaguy Saffouh El Hajj, Ricky D Turgeon, Kyle John Wilby
The Canadian Journal of Hospital Pharmacy|September 13, 2017
Pharmacist Performance of Physical Assessment: Perspectives of Clinical Pharmacists Working in Different Practice SettingsDoson Chua, Fatima Ladha, Robert T Pammett, et al.
The Canadian Journal of Hospital Pharmacy|March 5, 2019
Evaluation of Physical Assessment Education for Practising Pharmacists: A Cross-Sectional SurveyArden R Barry, Greg Egan, Ricky D Turgeon, et al.
The American Journal of Medicine|January 3, 2015
Antiviral treatment of Bell's palsy based on baseline severity: a systematic review and meta-analysisRicky D Turgeon, Kyle J Wilby, Mary H H Ensom
Canadian Family Physician Medecin De Famille Canadien|December 15, 2021
Medication management for heart failure with reduced ejection fraction: Clinical pearls for optimizing evidenced-informed therapyArden R Barry, Lynette Kosar, Sheri L Koshman, et al.
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|January 14, 2016
Updated guidelines for the management of dyslipidemia and prevention of cardiovascular disease by pharmacistsRicky D Turgeon, Todd J Anderson, Jean Grégoire, et al.
European Cardiology|April 18, 2022
Cryoablation or Drug Therapy for Initial Treatment of Atrial FibrillationJason G Andrade, Ricky D Turgeon, Laurent Macle, et al.
ESC Heart Failure|February 19, 2026
Independent external validation of the LIFE-HF clinical prediction model using the GUIDE-IT trialRicky D Turgeon, Nathaniel M Hawkins, Mohsen Sadatsafavi, et al.
European Heart Journal|March 17, 2022
P2Y12 inhibitor adherence trajectories in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prognostic implicationsRicky D Turgeon, Sheri L Koshman, Yuan Dong, et al.
The Canadian Journal of Hospital Pharmacy|January 27, 2017
Characterization of Venous Thromboembolism Risk in Medical Inpatients Using Different Clinical Risk Assessment ModelsReza Rafizadeh, Ricky D Turgeon, Josh Batterink, et al.
Pageof 12